May 20, 2018
1 min watch
Save

VIDEO: Surgeons report positive experience with Xen implant for refractory glaucoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting here, Manjool Shah, MD, discusses his experience as well as reports from other surgeons on their use of the Xen implant (Allergan) at 1 year for the treatment of refractory glaucoma.